Skip to content
healthcare.dev

Lisinopril and Hydrochlorothiazide

NDC 70518-0382, Lisinopril and Hydrochlorothiazide, tablet, from REMEDYREPACK INC..

Product NDC
70518-0382
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077912
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0382 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCHLOROTHIAZIDE12.5 mg/1
  • LISINOPRIL20 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70518-0382-57051803820530 TABLET in 1 BLISTER PACK (70518-0382-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3857ac53-0435-4d68-8066-c22291414889

Use it

Look up 70518-0382 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0382 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-0382. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.